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Summary
Oncogene amplification is an important process in human tumorigenesis, but its underlying mechanism is currently un-
known. Cytogenetic analysis indicates that amplification of drug-selected genes in rodent cells is driven by recurrent
breaks within chromosomal common fragile sites (CFSs), via the breakage-fusion-bridge (BFB) mechanism. Here we show
that BFB cycles drive the intrachromosomal amplification of the MET oncogene in a human gastric carcinoma. Our molecular
evidence includes a “ladder-like” structure and inverted repeat organization of the MET amplicons. Furthermore, we show
that the breakpoints, setting the centromeric amplicon boundaries, are within the CFS FRA7G region. Upon replication
stress, this region showed perturbed chromatin organization, predisposing it to breakage. Thus, in vivo induction of CFSs
can play an important role in human oncogenesis.
Introduction an initial break (or telomere dysfunction) of a chromatid bearing
the selected gene might lead to fusion of the uncapped sister
A complex pattern of chromosomal aberrations is a common chromatids after replication. The resulted dicentric chromosome
phenomenon in many cancers (Mitelman et al., 1997), but the forms an anaphase bridge between the centromeres, which will
mechanisms that initiate, direct, and enable this instability are break while moving to opposite poles of the mitotic spindle. If
still poorly understood. One form of cancer instability is intrach- this break occurs centromeric to the selected gene, a duplication
romosomal amplification of large genomic regions containing of the region between the breaks is gained. Several recurrent
oncogenes. Amplification and subsequent overexpression of cycles of chromosomal fusion and breakage under the appro-
human oncogenes has been demonstrated for a variety of differ- priate selection lead to intrachromosomal amplification. Impor-
ent neoplasias, and is thought to play an important role in the tantly, the recurrent breaks defining the boundaries of the in-
progression of tumor cells toward an increased malignancy (Bri- duced amplicons were found to coincide with the cytogenetic
son, 1993). location of specific hamster chromosomal loci (Kuo et al., 1994;
Early events of gene amplification in cancer are usually un- Coquelle et al., 1997), defining as common fragile sites (CFSs)
available for studying. Thus, model systems in cultured rodent (Glover et al., 1984).
cells were developed, in which amplification of genes conferring CFSs are specific regions in mammalian chromosomes that
drug resistance is induced and selected for. Analysis of the are prone to breakage and rearrangements. They appear as
structure and organization of such induced amplicons sug- constrictions, gaps, or breaks in metaphase chromosomes of
cells exposed to inhibitors of DNA replication, among which aregested that the mechanism underlying the early amplification
events is breakage-fusion-bridge (BFB) cycles (Toledo et al., known mutagens and carcinogens (Yunis et al., 1987), as well
as inducers and enhancers of amplification events (Stark et al.,1992). According to this model (McClintock, 1951) (Figure 1),
S I G N I F I C A N C E
Here we provide molecular evidence that the chromosomal breakpoints that drive oncogene amplification occur nonrandomly.
Our results show that the breaks setting the boundaries of amplified genomic regions might occur at specific chromosomal loci
defined as fragile sites. There are 100 fragile sites in the human genome estimated to encompass 100 Mb of DNA. The fragility
of these sites is induced under conditions which interfere with DNA replication. We suggest that during in vivo tumorigenesis, cells
can undergo genetic changes and/or be exposed to environmental factors that interfere with DNA replication and induce fragile
site expression. Since many of the drugs used in cancer therapy are potential inducers of both fragile sites and gene amplification,
they can lead to chromosomal rearrangements and further contribute to cancer development. Better understanding the effect of
these drugs on the mechanisms that initiate, direct, and enable chromosomal instability is of major clinical importance and might
lead to the development of better therapeutic approaches.
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a human gastric carcinoma and found that they fit with the BFB-
CFS model. Our results suggest that recurrent breakage at CFS
can lead to in vivo amplification of human oncogenes and other
chromosomal rearrangements, thus shedding a new light on
the role of CFSs in cancer.
Results
Equal-spaced organization of an amplified oncogene
in a human cancer
If BFB cycles and recurrent breaks underlie oncogene amplifi-Figure 1. A scheme illustrating gene amplification via breakage-fusion-bridge cy-
cles cations, an equal-spaced organization of the amplified copies
would be expected to be preserved in some amplificationAmplicons, yellow triangles; telomeres, orange (p-arm) or black (q-arm) circles;
centromeres, orange rectangles. A: Interphase—an initial break gives rise to an events, in which the initial organization was stabilized and pre-
uncapped chromatid carrying the selected gene. B: Metaphase—fusion of the 2 served. We thus searched the literature for amplification of hu-
uncapped sister chromatids results in a dicentric chromosome. C: Anaphase—the
man oncogenes that resemble a ladder-like structure. Such adicentric chromosome forms a bridge between the opposite poles. A break of
possible structure was noticed in the GTL-16 cell line, originatingthis chromosome leaves one daughter cell (D) with 3 copies of the selected gene,
and only one copy in the other cell (E). Under a selection, recurrent cycles of BFB from a human gastric carcinoma (Motoyama et al., 1986). In
will occur, resulting in further accumulation of amplicon copies. this hypotetraploid cell line, 2 copies of a marker chromosome
containing 10 copies of the MET oncogene appear in all cells
(Ponzetto et al., 1991), accompanied by overexpression and
high activity of the MET tyrosine-kinase (Giordano et al., 1989).
1989; Windle et al., 1991). They are classified as either rare or To study the amplicon organization in these cells, we applied
common, depending on their frequency within the population FISH using clones from the vicinity of MET, and evaluated the
and their mode of induction. CFSs are considered to be part results using confocal microscopy and computational image
of the normal chromosome structure and thought to be present analysis (Hellman et al., 2000). As shown in Figure 2A, a clear
in all individuals (Sutherland and Richards, 1995). In tissue cul- ladder-like structure with 4 distinct intervals was visualized on
tures, induced CFSs are preferential targets for chromosomal the chromosomes carrying the amplification. This equal-spaced
rearrangements, sister chromatid exchange, and integration of organization suggests that all the amplicons were bordered by
foreign DNA (Smith et al., 1998). So far, molecular analysis breakpoints at the same chromosomal region. Thus, GTL-16
of CFSs has only been performed in human and mouse. This cells provide a suitable system to investigate the involvement
includes the partial identification of 4 sites (FRA3B, FRA7H, of a BFB mechanism and the role of fragile site expression in
FRA7G, and FRA16D) out of90 that have been cytogenetically cancer amplification.
defined in the human genome (Boldog et al., 1997; Mishmar et
al., 1998; Huang et al., 1998a; Paige et al., 2000; Shiraishi et al., Induction of perturbed chromatin organization
2001). These studies reveal that the fragile regions (the regions along the CFS FRA7G region
which exhibit fragility under the induction conditions) might en- Previous analysis in GTL-16 cells defined the centromeric
compass hundreds of kilobases (kb) of DNA. The molecular boundary of the amplicons within an interval of several Mb at
basis underlying their fragility is largely unknown; however, sev- 7q31.1-7q31.2 (Ponzetto et al., 1991). The only CFS in this
eral studies show that intrinsic features of the fragile sequences interval is FRA7G, cytogenetically mapped to 7q31.2 (Yunis et
might lead to perturbed fork progression. This can result in al., 1987). Although Huang et al. characterized 300 kb span-
delayed replication along the fragile regions (Le Beau et al., ning the fragile region (Huang et al., 1998a; 1998b), the entire
1998; Wang et al., 1999; Hellman et al., 2000), which is thought FRA7G region and its location relative to MET have not yet been
to interfere with the normal chromatin organization of the fragile defined (Tatarelli et al., 2000).
region in metaphase, leading to fragility (Laird et al., 1987). To further define and characterize the entire FRA7G region,
The ex vivo induction of CFSs was suggested to trigger and we constructed a physical map covering 10 Mb of 7q31 by
drive the amplification of drug-selected genes in rodent cells isolating BAC clones that bridged contiguous sequenced re-
(Coquelle et al., 1997). However, the role of CFSs in the in vivo gions from the public and the Celera databases (Figure 3E). We
amplification of human oncogenes remains unclear. Here we further determined the location of clones relative to FRA7G gaps
investigate the possibility that recurrent chromosomal breaks and constrictions by using FISH on metaphase chromosomes
in common fragile regions can drive BFB cycles, leading to induced to exhibit CFSs. A clone was considered as spanning
amplification of human oncogenes. Under this model (Figure the fragile region if on different chromosomes from the same
1), the following would be predicted: (1) equal-spaced organiza- preparation its hybridization signals appeared centromeric or
tion of intrachromosomal amplicons, visualized by fluorescence telomeric to the FRA7G gaps, or crossed the gaps (“both sides”)
in situ hybridization (FISH) as a “ladder-like structure;” (2) clus- (Mishmar et al., 1998). Since there are several CFSs along 7q,
tering of the recurrent breaks within a CFS region; (3) inverted we used computational image analysis to identify FRA7G (Ex-
repeat organization of all the amplified copies along the same perimental Procedures). We were able to define 2 distinct zones
chromosomal arm; and (4) absence of sequences telomeric to within the region of FRA7G. One zone encompassed 700 kb
the endogenous amplified region in the chromosome carrying (dark blue in Figures 3B and 3F) and comprised clones (c169h6,
the amplified copies. In this study, we reconstructed the molecu- AC002066, and V203C) that appear to span the FRA7G gaps
(Figure 2B, Table 1). The more telomeric 19d10 clone (RAY1/lar events that led to the amplification of the MET oncogene in
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cells. To confirm the mapping of the opposite orientation region
and to further exclude the possibility of a chromosomal re-
arrangement, we performed FISH on metaphase chromosomes
expressing FRA7G in another human cell line, PANC-1. A similar
telomeric orientation of clone AC002089 was identified in these
cells (data not shown). These results suggest that the opposite-
orientation pattern reflects an unusual chromatin organization
of the fragile region in metaphase chromosomes exhibiting fra-
gility. Thus, the analysis of the entire FRA7G region showed
that fragile site induction can lead to an unusual chromatin
organization (gaps, breaks, and spanning or opposite-orienta-
tion organization) along 5 Mb of DNA.
Perturbed DNA replication along FRA7G
Perturbed DNA replication was previously found along CFS se-
quences (Le Beau et al., 1998; Wang et al., 1999; Hellman et
al., 2000). To further define the region encompassed by FRA7G,
we analyzed the replication pattern along that region, using
FISH on S-phase nuclei. In this method, a high percentage of
unreplicated alleles (single hybridization dot, S signal) indicates
Figure 2. Organization of the MET amplicons relative to FRA7G region that the region is replicated relatively late in the S-phase, while
A: The organization of the MET amplicons along a GTL-16 metaphase chromo- a high percentage of replicated alleles (double dot, D signals),
some, analyzed by FISH using clone V193A as a probe. Insert: Computational indicates a relatively early replication time. For most sequences,
representation of the FISH signals (red) and the DAPI staining (blue) along the the 2 alleles replicate in a synchronous manner and have a lowamplified marker chromosome. B: FISH analysis of the FRA7G region. Upper
percentage (10%–20%) of SD signals (Selig et al., 1992).panels: metaphase chromosomes expressing FRA7G (white triangles), stained
with propidium iodide (PI). FRA7G are seen as unstained gaps. Bottom: the same First we analyzed the replication pattern of the nonfragile
chromosomes probed with a MET clone (cosmid c169h6, green arrow) and a region telomeric to FRA7G (Figure 3). This analysis has revealed
reference clone from 7q32 to mark chromosome 7. The MET signals appear 2 distinct replication time zones: the region adjacent to FRA7G
telomeric (left) or centromeric (right) to FRA7G gaps. C: Upper panel: A metaphase
(cosmid clones c172d6 and c19d10, orange in Figures 3C andchromosome stained with PI, expressing both FRA7H and FRA7G. Bottom: The
3G) showed a relatively early replication time and an allelicsame chromosome probed with YAC HSC7E125 (FRA7H) and BAC AC002461
(FRA7G). Note the opposite orientation of both clones relative to the physical synchronous replication pattern (18% and 19% SD, Table 2)
map. D: The order of clones along the FRA7G region, analyzed by FISH on while the more telomeric part (CW44 and CNH24, dark green
interphase nuclei from the GM00847 cells (each has 4–6 chromosomes 7). Left: in Figures 3C and 3G) showed a late and synchronous patternAC003080 (green); AC025297 (red); AC002461 (green); AC002465 (red). Right:
(12% and 10% SD). Thus, the region defined by the cytogeneticHSC7E160 (7q31.1) (red); AC073137 (green); AC002461 (green); AC002465 (red).
Inserts: a magnification of one chromosome from each nucleus. Note that the analysis as the telomeric nonfragile region indeed presented a
order found in these FISH experiments is the expected order, based on the normal replication pattern with early and late replication time
sequenced contigs (Figure 3). zones, which likely correspond to the R-band 7q31.2 and the
G-band 7q31.3, respectively (Figure 3A).
We then analyzed the replication pattern of clones that span
the FRA7G gaps. All of these clones (149e12, 182b3, 63e3,
ST7 locus) showed hybridization signals only telomeric to the 19d5, and V193A, pink in Figures 3C and 3G) showed early
FRA7G gaps, indicating that the telomeric border of this zone replication time, but with high levels of allelic asynchrony (29%–
must be between the MET and the RAY1/ST7 loci (Figure 3 and 32% SD, Table 2). Such high levels of asynchrony have pre-
Table 1). viously been found along the CFS FRA7H and might reflect
The other zone encompassed 3–4 Mb (light blue in Figures perturbed DNA replication (Hellman et al., 2000). However, it
3B and 3F) and was comprised of clones showing an unusual might also reflect allele-specific replication time of regions har-
hybridization pattern, since they hybridize mostly to the telo- boring parentally imprinted genes (Kitsberg et al., 1993a). We
meric side of the FRA7G gaps, even though they are located excluded this possibility by analyzing the replication pattern of
more centromeric on the physical map (clones AC034112 to this region in an isodisomic cell line (CF33-3) carrying 2 maternal
AC002463, Figure 2C and 3F and Table 1). The centromeric chromosomes 7 (Hellman et al., 2000). The FRA7G clone V193A
border of this zone was found between AC002463 and showed asynchronous replication in both normal (CF33-2) and
AC003080. To exclude the possibility that the opposite orienta- the isodisomic cells (30% and 27% SD, respectively), indicating
tion of these clones resulted from an inversion or translocation of that its asynchrony is not a result of allele-specific replication
the region between AC002463 and AC034112 in the GM00847 time. It is important to note that the identified asynchrony might
cells, we performed a dual-color FISH analysis on interphase also result from an abnormal separation of the sister chromatids
nuclei from cells grown under normal growth conditions. The as part of the unusual chromatin organization of the region.
signal order of 2 sets of clones was analyzed in at least 50 We further investigated the replication pattern along the
interphase chromosomes lying in a linear position (Figure 2D). FRA7G region by analyzing the replication time differences be-
This analysis showed that the order of clones along the entire tween adjacent sequences. The cosmid clone c63e3 replicated
region was as expected from the physical map, excluding the before c182b3 (35 kb apart) in 62% of the nuclei, and the clone
c169h6 replicated before c149e12 (150 kb apart) in 76% of thepossibility of a chromosomal rearrangement in the GM00847
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Figure 3. Maps of the FRA7G region
A: Reference genes and polymorphic markers at
7q31.1–7q31.3. B: A region spanning the cytogenetic
gaps and constrictions (dark blue), and a region
showing telomeric signals of clones that are located
more centromeric on the physical map (“opposite
oriented”) (light blue). C: Regions showing normal
(synchronous) and early replication pattern in orange,
normal and late in dark green, and unusual (asyn-
chronous) and early in pink. D: The boundaries of the
GTL-16 amplicons, 5 region in red, 10 in green.
Below are indicated the YAC clones used in the anal-
ysis of the telomeric boundary. E: The set of Celera
DNA sequence scaffolds (upper line) connect-
ed by BAC clones (bottom lines). The numbers
indicate the size of each sequence in Mb. The
sequence names from left to right are:
i-GA_x8Y8FG7; ii-GA_x8Y8FKQ; iii-GA_
X2HTBKNJPOH; iv-GA_x2HTBL4GTR2; v-GA-
x8WU11E; vi-GA_x2HTBKNGALA; vii-GA_
x2HTBI2VJAN. The BAC clones or accession num-
bers from left to right are: AC073346; CIT-2172F3;
AC032017; AC073901; CIT-2012G19; AC015621;
NH032P06; NH516A21; AC005016. F: Clones used
for the cytogenetic analysis of FRA7G gaps and con-
strictions. G: Clones used for the replication analysis.
H: Clones used for the analysis of the amplicon
boundaries and the copy number within the amplified
region. The colors of the clones in F–H are the same
as in B–D.
nuclei. The ability to clearly detect the replication time order of 7q31. In this analysis, amplified sequences were detected as
2 groups of multiple hybridization signals (representing the 2such adjacent clones suggested an unusual replication rate
along FRA7G, as previously found along FRA7H (Hellman et al., amplified chromosomes), while nonamplified sequences were
detected as 4 isolated signals (representing the 4 copies of2000). Hence, the replication analysis supported the cytogenetic
identification of the FRA7G region, and showed that this region chromosome 7 in these cells; examples in Figure 4A). Using this
has an intrinsic replication perturbation, in addition to its induced approach, we defined the telomeric boundary of the amplified
chromatin perturbation. region between YACs HSC7E437 and HSC7E137 (Figure 3D)
and the centromeric boundary between BACs AC025297 and
AC073137 (Figure 3H). Very weak signals were seen withBreakpoints within FRA7G set the centromeric
AC023466, indicating that the breakpoint is probably within thisboundaries of the MET amplicons
clone. These results show that the centromeric boundary of theIf the amplification of MET in GTL-16 cells originated by a BFB-
amplified region is within the chromatin perturbation region ofCFS mechanism, then the centromeric boundaries of the ampli-
cons are expected to lie within the FRA7G region. In a previous FRA7G, as expected from the model.
Since FRA7G encompasses a large genomic region, andstudy, the boundaries of the MET amplified region were esti-
mated to lie at least 1 Mb centromeric and 2 Mb telomeric to assuming that the 10 amplified copies were generated by BFB
cycles, more than one breakpoint was expected within the frag-MET (Ponzetto et al., 1991). To further define the boundaries,
we applied dual-color FISH on GTL-16 nuclei using clones from ile region. In order to identify additional breakpoints, we ana-
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Table 1. FISH analysis of hybridization signals on metaphase chromosomes Table 2. Replication pattern (% SD, SS, and DD) of S-phase nuclei
exhibiting FRA7G
Clones SD SS DD
Number of signals
Synchronous and late
Clones Centromeric Both sides Telomeric
CW44 12 73 15
CNH24 10 77 13c19d10 (RAY1/ST7) 0 0 21
c169h6 (MET) 2 1 17 Synchronous and early
AC002066/V203C 12 1 21
C172d6 18 37 45AC034112/AC002461 0 0 40
C19d10 19 45 36AC002089 1 2 43
AC025297 2 1 33 Asynchronous and early
AC073137 1 0 54
C149e12 31 34 35AC002463 1 1 40
C182b3 29 31 40AC003080 18 0 3
C63e3 32 27 41
The clones are ordered in accordance with the physical map, telomeric C19d5 30 33 37
(top of the table) to centromeric (bottom). The results of clones covering V193A 29 28 43
the same genomic region were combined.
Synchronous and early
AC002461 18 25 57
AC025297 16 28 56
The clones are ordered according to the physical map, telomeric (top of
lyzed the level of amplification along the amplified region by the table) to centromeric (bottom).
counting FISH signals in interphase nuclei (only nuclei in which
the analyzed region was replicated were considered, Experi-
mental Procedures). The analysis has revealed 2 distinct levels
of amplification. Most (8/10 Mb) of the amplified region, covered terphase chromosomes. In the case of an inverted repeat organi-
by clones HSC7E437, AC002465, and V193A, showed 20  5 zation, signals of a clone from the edge of the amplicon are
signals per group (green in Figures 3D and 3H, and Figure 4B). expected to appear adjacent to each other, while signals of a
This indicated that each marker chromosome carried 10 copies clone from the center are expected to flank them (Figure 5A).
of the amplified region, in agreement with previous studies In contrast, in the case of a direct repeat (head to tail) organiza-
(Ponzetto et al., 1991). However, the centromeric 2 Mb of the tion, the signals from the edge and those from the center are
amplified region, encompassed by BAC clones AC017003, expected to alternate, and in a case of a random organization,
AC074000, and AC025297 (red in Figures 3D and 3H), showed no pattern is expected. The analysis of paired probes, one from
only 103 signals/group, indicating only 5 copies/chromosome the center and the other from the centromeric edge of the GTL-
(Figure 4B). Hence, 2 breakpoints were identified in the centro- 16 amplicon, showed a pattern (Figure 5B) consistent with an
meric boundary of the MET amplification: one between the high- inverted repeat organization, as predicted by the BFB model.
and the low-amplified regions (between V193A and AC017003),
The structure of the amplified chromosomeand the other between the low- and the nonamplified regions
In many amplification events in cancer cells, the initial amplicon(between AC025297 and AC073137). These 2 breakpoints lie
organization is hampered by secondary rearrangements whichwithin the FRA7G region, as predicted by the BFB-CFS mecha-
occur during the cancer development. However, in GTL-16 cells,nism. The final amplification break (accounting for8 MET cop-
the amplicon organization indicates that such secondary re-ies, Figure 5A, stage iv) is expected to appear in only one copy
arrangements did not occur in these cells. By using spectral(Figure 5A, stage v). This final breakpoint could not be identified
karyotyping (SKY) and FISH analyses we found that the chromo-since a change in only one FISH signal is below the resolution
some arm harboring the MET amplicons is fused to the centro-of the analysis.
mere and the short arm of chromosome 12 (Figures 4C and
4D). Such a fusion could have prevented secondary BFB cycles,The GTL-16 amplicons are organized
due to the recapping of the broken chromosome end (Toledoas inverted repeats
et al., 1992). Importantly, FISH analysis of clones from the telo-
Another important prediction of the BFB model is an inverted
meric part of 7q (clones HSC7E137 from 7q31.3 and c53g3
repeat organization of the amplicons (Figure 1). The first indica- from the MEST locus in 7q32) showed that sequences telomeric
tion for such an organization in GTL-16 cells was the 5-step to the endogenous amplified region are absent in the marker
ladder as demonstrated by hybridization with clone V193A, chromosome, as predicted by the BFB model. In addition, the
which is 2 Mb from the edge of the amplicon (Figure 2A). This karyotype analysis of GTL-16 showed that most chromosomes
type of pattern would be expected using a FISH probe from the have 4 copies, while chromosome 7 has 2 normal and 2 deleted
edge of the amplicon, assuming an inverted repeat organization. copies, and chromosome 12 and the 7-12 fused marker chromo-
An alternating pattern between close signals (below the resolu- some each appear in only 2 copies (Rege-Cambrin et al., 1992).
tion of FISH at metaphase) and distant signals should be ob- This organization further supports our hypothesis that the ampli-
served, and this could result in a 5-step ladder, with each rung fied chromosome was stabilized by fusion with the short arm
corresponding to 2 copies of the MET amplicon (Figure 5A). As of chromosome 12 following the amplification. However, the
can be seen in Figure 2A, this was indeed the identified pattern. fusion between the amplicons and chromosome 12 sequences
Since FISH resolution is much higher in interphase (100 could have also resulted from a recombination event prior to
the BFB cycles.kb), we further examined the amplicon organization in in-
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Figure 5. Reconstruction of the events which led to the MET amplification in GTL-
16 cells
A: The sequence of events, leading to amplification of MET in the GTL-16 cells.
The 5 region is shown in red, the 10 region in green, induced FRA7G as black
rectangles, uninduced as empty rectangles. Only intact (nonrearranged) fragile
regions are marked. Other elements have the same color code as in Figure 1. B:
Upper: The expected hybridization pattern along one chromatid of the amplified
chromosome. Bottom: A replicated amplified chromosome of a GTL-16 in-
terphase, hybridized with clone AC025297, from the 5 amplified region (red)
and AC002465 from the 10 amplified region (green).
Figure 4. The organization of the amplified chromosome in the GTL-16 cells
A: FISH analysis of the amplicon boundaries. Left: an interphase nucleus hybrid-
ized with the MET clone c169h6 (green) and with clone V193A (red). The signals
occur during subsequent BFB cycles. The regions between theof both probes colocalize and appear yellow. Right: an interphase nucleus hybrid-
breakpoints are expected to be included only in a subset of theized with V193A (red) and HSC7E137 (green). HSC7E137 signals appear only on
the 4 nonamplified copies of chromosome 7 (arrowheads), indicating that this amplicons (Figure 5). Here we identified 2 breakpoints (2 Mb
clone is not included in the amplicon. B: The level of amplification of clones apart) that set the centromeric boundaries of the MET ampli-
encompasses the amplified region, determined by counting FISH signals in in-
cons. Both breakpoints lie in a region adjacent to the FRA7Gterphase nuclei. Only nuclei in which the analyzed region was replicated were
spanning region, which showed unusual chromatin organizationconsidered. C: Left: SKY analysis of the amplified chromosome. Chromosome
12 sequences in green, chromosome 7 in orange. Right: G-banding of the same upon fragile site induction. Such an unusual organization (the
chromosome. D: An interphase nucleus from GTL-16 cells hybridized with a “opposite orientated” phenomenon) was found around the
chromosome 12 centromeric probe (green) and V193A (red). spanning region of another CFS, FRA7H (Mishmar et al., 1998)
(Figure 1C). Thus, we suggest that CFSs might consist of “core
sequences” and “affected sequences.” The core sequences
(the spanning regions) have an unusual replication pattern (LeDiscussion
Beau et al., 1998; Wang et al., 1999; Hellman et al., 2000) (Table
2), which predispose them to additional replication delay underHere we demonstrate the role of a BFB-CFS mechanism in the
conditions that induce fragility. The replication delay might per-amplification of a human oncogene in vivo. Our study provides
turb the condensation of the chromatin, resulting in large regionsevidence for all the predictions of this model: (1) An equal-
showing perturbed chromatin organization at metaphase (Figurespaced organization of the amplified units, visualized as a lad-
1C). The unusual organization of the chromatin loops aroundder-like structure. (2) Clustering of the recurrent breaks within
the gaps might account for the “opposite-orientation” phenome-CFS regions (rather then distribution of the breaks along the
non. (3) Symmetric and alternate organization of the amplifieddistance between the oncogene locus and the centromere). Our
copies, which fits with an inverted repeat organization of thestudy provides molecular evidence that breakage leading to
amplified region. As can be seen in Figure 5B, such an organiza-oncogene amplification preferentially occurs within CFS re-
tion was found for the 10 and 5 amplified regions in GTL-gions. Since human CFSs encompass large genomic regions,
different breakpoints within the fragile region are expected to 16 cells. (4) Absence of sequences telomeric to the endogenous
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amplified region, in chromosomes carrying the amplified copies. telomeric associations, and dicentric ring chromosomes, in both
tissues and cell lines from a variety of solid tissues cancersIn the GTL16 cells, no sequences telomeric to HSC7E137 were
identified in the marker chromosome. Hence, for the amplifica- (2000a). Artandi et al. showed that BFB cycles promote nonre-
ciprocal translocations and epithelial cancers in mice (2000).tion of MET in the GTL-16 cells, all the predictions of the BFB-
CFS model have been verified at the molecular level. It therefore Shuster et al. reported a pattern of rearrangements in oral squa-
mous cell carcinoma cell lines that fit to the BFB mechanismappears that intrachromosomal amplification of human onco-
genes may arise by the same mechanism as suggested for the of amplification in human chromosome 11q13, a region that
harbors several oncogenes (2000). Our search of the literatureamplification of drug resistant genes in rodent cells.
We suggest the following sequence of events (diagrammed identified additional examples of symmetric amplicon organiza-
tion, which might indicate ladder-like organizations in amplifica-in Figure 5) for in vivo oncogene amplification in tumor cells:
(1) An initial break sets the telomeric boundary of the amplified tions of several human oncogenes, including KRAS2 (Figure 7
in Gisselsson et al., 2000b), MLL (Figure 3C in Kakazu et al.,unit and leads to deletion of the region telomeric to the break
(Figure 5A). The break might occur spontaneously, or as part 1999) and C-MYC (Figure 4 in Falzetti et al., 2000). Hence,
the lack of visual ladder-like structures in most human tumorsof general chromosomal instability that characterizes early
stages of many cancer types (Lengauer et al., 1998), such as containing intrachromosomal amplifications probably reflects
their late stage in the cancer progression, during which second-nonreciprocal translocations caused by telomere dysfunction
(Artandi et al., 2000). However, the initial break might also occur ary rearrangements can hamper the recognition of the initial
amplicon organization.at CFSs due to exposure to induction conditions. In GTL-16
cells, this break occurred at 7q31.3, between YACs HSC7E437 These findings show that the expected results of BFB-CFS
amplification could be found in a variety of human tumors, sug-and HSC7E137. (2) The initial break generates uncapped chro-
mosomal ends, which can lead to end-fusion of the sister chro- gesting that fragile sites may play an important role in cancer.
Yunis and Soreng (1984) put forward the hypothesis that CFSsmatids, resulting in a dicentric chromosome (Figure 5A). (3) At
the same stage, the cells can undergo additional genetic play a role in cancer instability, based on the correlation between
chromosomal bands in which CFSs are mapped and bandschanges and/or be exposed to environmental factors (e.g., hyp-
oxia, deregulation of the nucleotides pools, and treatment with harboring cancer breakpoints and/or oncogenes. Subsequently,
deletions of regions containing tumor suppressor gene(s) werecytotoxic drugs) that interfere with DNA replication and induce
fragile site expression (Yunis et al., 1987). All these conditions found at the human CFSs FRA3B, FRA7G, and FRA16D regions,
indicating instability in cancer cells (reviewed in Smith et al.,are also enhancers of gene amplification (Stark et al., 1989;
Coquelle et al., 1998; Poupon et al., 1996). Importantly, FRA7G 1998; Mangelsdorf et al., 2000). However, these studies left
open the question of whether this instability is the outcome ofwas shown to be induced by several agents, such as methotrex-
ate or actinomycin D (Yunis et al., 1987), which are inducers an intrinsic instability conferred by the fragile sites or due to
the selection of altered cancer genes located in these regionsof gene amplification. The unusual chromatin organization of
induced fragile regions predisposes them to chromosomal (Smith et al., 1998). Our study suggests that these cancer
breakpoints are indeed the outcome of an intrinsic instabilitybreaks during anaphase, when the dicentric chromosome is
segregating to opposite poles (Figure 5). In GTL-16 cells, this conferred by the fragile site sequences, since in the case of
intrachromosomal amplification of large genomic regions, theevidently led to a break within FRA7G, between the 10 and
the 5 amplified regions. (4) Additional fusion-bridge-breakage breaks are distant from the targeted genes and thus are not
affected by selection. Thus, it is important to investigate thecycles occur, giving rise to the amplification of the region be-
tween the breaks. In GTL-16 cells, 3 such BFB cycles presum- molecular organization of additional intrachromosomal onco-
gene amplifications (such as C-MYC, cyclin D1, MLL) and theably occurred, resulting in 16 extra copies of the MET amplicon.
(5) Eventually, the selection pressure disappears once the onco- role of the fragile sites in their vicinity (FRA8C or D, FRA11F or
A, and FRA11G, respectively).gene has attained sufficient amplification. Since MET protein is
known as a scatter factor, which triggers cell proliferation, cell In many cancers, chromosomal instability precedes and pro-
motes the dysfunction of specific cancer genes (Lengauer etsurvival, cell motility, invasion of extracellular matrix, and in-
duced angiogenesis (Prat et al., 1998), we postulate that in al., 1998), leading to the generation and/or to the progression
of malignancy (Rennstam et al., 2001). Our results suggest thatthe GTL-16 cells, the disappearance of the selection pressure
(which also induces fragility) might have occurred as a result of under conditions which induce the expression of CFSs, these
regions can direct chromosomal rearrangements that play athe development of motility and/or angiogenesis ability in cells
carrying extra copies of MET, leading to reoxygenation of the significant role in cancer development. Since many of the drugs
used in cancer therapy are potential inducers of both fragiletumor cells. (6) Secondary BFB cycles can occur, hampering
sites and amplification, they can lead to chromosomal re-the initial organization of the amplicons, unless the uncapped
arrangements and further contribute to cancer development.chromosomal ends stabilize within a short time following ampli-
Thus, a better understanding of the causal relationship betweenfication. In the GTL-16 cells, the amplified chromosome fused
cancer therapeutic agents and their specific targets (specificwith chromosome 12, and the breakage of this dicentric 7-12
fragile sites and oncogenes) will provide the required informationchromosome was stabilized, giving rise to the marker chromo-
for developing better therapeutic approaches.some (Figures 4C and 4D and Figure 5A, stage vi), probably
shortly following the amplification.
Experimental proceduresRecent studies suggest that BFB cycles represent a general
mechanism leading to cancer instability. Gisselson et al. investi- Cells and growth conditions
gated cancer cells with high intratumor heterogeneity, and found The cell lines used in this study: GTL-16, a gastric carcinoma cell line with
amplification of the MET oncogene (Motoyama et al., 1986); Manca, a lym-evidence for frequent BFB events, including anaphase bridges,
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Boldog, F., Gemmill, R.M., West, J., Robinson, M., Robinson, L., Li, E.,phoma cell line; CF33-2, a normal lymphocyte cell line; and CF33-3, a
Roche, J., Todd, S., Waggoner, B., Lundstrom, R., et al. (1997). Chromosomechromosome 7 isodisomic lymphocyte cell line (Hellman et al., 2000).
3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol.GM00847 (National Institute of General Medical Sciences, Camden, NJ),
Genet. 6, 193–203.a simian virus 40 (SV40)-transformed human fibroblast cell line. PANC-1
(American Type Culture Collection, Rockville, MD), a tumor-cell line estab- Brison, O. (1993). Gene amplification and tumor progression. Biochim. Bio-
lished from a carcinoma of the pancreas. All cell lines except GM00847 were phys. Acta 1155, 25–41.
grown in RPMI medium containing 10% fetal calf serum. GM00847 was
Coquelle, A., Pipiras, E., Toledo, F., Buttin, G., and Debatisse, M. (1997).grown in MEM-EAGLE medium supplemented with 10% fetal calf serum.
Expression of fragile sites triggers intrachromosomal mammalian gene am-
plification and sets boundaries to early amplicons. Cell 89, 215–225.Contigs, sequences, and DNA probes
A DNA sequence-based map of chromosome 7q31.1 to 7q31.3 was con- Coquelle, A., Toledo, F., Stern, S., Bieth, A., and Debatisse, M. (1998). A
structed by comparing and combining information acquired from the Celera new role for hypoxia in tumor progression: induction of fragile site triggering
scaffold assemblies and from high-throughput (HTGS) and finished se- genomic rearrangements and formation of complex DMs and HSRs. Mol.
quence from the public GenBank database. Physical gaps were bridged by Cell 2, 259–265.
BAC clones that have either been sequenced or whose end-sequence (TIGR
Falzetti, D., Vermeesch, J.R., Matteucci, C., Ciolli, S., Martelli, M.F., Marynen,BAC End Sequence Database) was known or generated. BLAST2 analysis
P., and Mecucci, C. (2000). Microdissection and FISH investigations in acutewas used to align all sequences. The assembled map with no physical
myeloid leukemia: a step forward to full identification of complex karyotypic(clone) gaps represents a consistent presentation of order of DNA markers,
changes. Cancer Genet. Cytogenet. 118, 28–34.in comparison to our other studies which used the additional technologies
of radiation and somatic cell hybrid mapping, and FISH (see http://www. Giordano, S., Ponzetto, C., Di Renzo, M.F., Cooper, C.S., and Comoglio,
genet.sickkids.on.ca/chromosome7/ for any additional information on clones P.M. (1989). Tyrosine kinase receptor indistinguishable from the c-met pro-
required). tein. Nature 339, 155–156.
Gisselsson, D., Pettersson, L., Hoglund, M., Heidenblad, M., Gorunova, L.,Fluorescent in situ hybridization (FISH) on interphase nuclei
Wiegant, J., Mertens, F., Dal Cin, P., Mitelman, F., and Mandahl, N. (2000a).FISH experiments on interphase nuclei (for mapping of FRA7G region, repli-
Chromosomal breakage-fusion-bridge events cause genetic intratumor het-cation time analysis, and mapping of the amplicon boundaries and copy
erogeneity. Proc. Natl. Acad. Sci. USA 97, 5357–5362.number) were performed as previously described (Hellman et al., 2000). To
avoid misinterpretation of the amplification signals, only nuclei in which the Gisselsson, D., Mandahl, N., Palsson, E., Gorunova, L., and Hoglund, M.
4 nonamplified copies of chromosome 7 were replicated (showed D signals) (2000b). Locus-specific multifluor FISH analysis allows physical character-
were considered in the analysis. Signals of 50 replicated amplified chromo- ization of complex chromosome abnormalities in neoplasia. Genes Chromo-
somes were counted for each probe. somes Cancer 28, 347–352.
Glover, T.W., Berger, C., Coyle, J., and Echo, B. (1984). DNA polymeraseCytogenetic analysis of the FRA7G region
alpha inhibition by aphidicolin induces gaps and breaks at common fragileGM00847 cells were grown on coverslips, and fragile sites were induced by
sites in human chromosomes. Hum. Genet. 67, 136–142.growing the cells in M-199 medium in the presence of 0.4 M aphidicolin
and 0.5% ethanol for 24 hr prior to chromosome fixation. FISH mapping of Hellman, A., Rahat, A., Scherer, S.W., Darvasi, A., Tsui, L.C., and Kerem,
the region encompassed by FRA7G was performed as previously described B. (2000). Replication delay along FRA7H, a common fragile site on human
(Mishmar et al., 1998). Since there are several aphidicolin induced fragile chromosome 7, leads to chromosomal instability. Mol. Cell. Biol. 20, 4420–
sites on 7q, their positions had to be carefully determined. Using the Image- 4427.
Pro Plus program (Media Cybernetics, Silver Spring, MD), the distance of
Huang, H., Qian, J., Proffit, J., Wilber, K., Jenkins, R., and Smith, D.I. (1998a).the fragile sites from the tip of the long arm of chromosome 7 was measured,
FRA7G extends over a broad region: coincidence of human endogenousrelative to the total length of the chromosome. According to the Genome
retroviral sequences (HERV-H) and small polydispersed circular DNAsDataBase mapping of the fragile sites, this value should be15% for FRA7H,
(spcDNA) and fragile sites. Oncogene 16, 2311–2319.30% for FRA7G, and 37% for FRA7F. Analysis based on 150 FRA7G
measurements indicated that it is located at 29% 2.5%. Observed cytoge- Huang, H., Qian, C., Jenkins, R.B., and Smith, D.I. (1998b). Fish mapping
netic gaps within 2 SD were considered to be FRA7G. of YAC clones at human chromosomal band 7q31.2: identification of YACS
spanning FRA7G within the common region of LOH in breast and prostate
Spectral karyotyping analysis cancer. Genes Chromosomes Cancer 21, 152–159.
Chromosome labeling was performed with the SKY fluorescent labeling kit
Kakazu, N., Taniwaki, M., Horiike, S., Nishida, K., Tatekawa, T., Nagai, M.,(Applied Spectral Imaging, Migdal HaEmek, Israel) according to the manufac-
Takahashi, T., Akaogi, T., Inazawa, J., Ohki, M., and Abe, T. (1999). Combinedturer’s protocol. Chromosomes were counterstained with DAPI. Image ac-
spectral karyotyping and DAPI banding analysis of chromosome abnormali-quisition was performed by use of a SD200 Spectracube (Applied Spectral
ties in myelodysplastic syndrome. Genes Chromosomes Cancer 26, 336–Imaging, Inc.) mounted on an Olympus BH-2 microscope using a custom
345.designed optical filter (SKY-1, Chroma Technology, Brattleboro, VT, USA).
Automatic identification of chromosomes was based on the measurement Kitsberg, D., Selig, S., Brandeis, M., Simon, I., Keshet, I., Driscoll, D.J.,
of the spectrum for each chromosome. Nicholls, R.D., and Cedar, H. (1993a). Allele-specific replication timing of
imprinted gene regions. Nature 364, 459–463.
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